{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:56:59Z","timestamp":1785787019074,"version":"3.56.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"DOI":"10.1038\/s41401-026-01891-w","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:17:36Z","timestamp":1785737856000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiomyocyte OTUD7b drives diabetic cardiomyopathy via deubiquitinating and stabilizing TAK1"],"prefix":"10.1038","author":[{"given":"Xue","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-ning","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-yang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu-qi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-rou","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-lin","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-juan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-bing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-zhong","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"1891_CR1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","volume":"17","author":"Y Tan","year":"2020","unstructured":"Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol. 2020;17:585\u2013607.","journal-title":"Nat Rev Cardiol"},{"key":"1891_CR2","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","volume":"57","author":"H Bugger","year":"2014","unstructured":"Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia. 2014;57:660\u201371.","journal-title":"Diabetologia"},{"key":"1891_CR3","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41420-023-01553-4","volume":"9","author":"J-L Huo","year":"2023","unstructured":"Huo JL, Feng Q, Pan S, Fu WJ, Liu Z, Liu Z. Diabetic cardiomyopathy: early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions. Cell Death Discov. 2023;9:256.","journal-title":"Cell Death Discov"},{"key":"1891_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1032268","volume":"13","author":"X Zhao","year":"2022","unstructured":"Zhao X, Liu S, Wang X, Chen Y, Pang P, Yang Q, et al. Diabetic cardiomyopathy: clinical phenotype and practice. Front Endocrinol. 2022;13:1032268.","journal-title":"Front Endocrinol"},{"key":"1891_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61901-z","volume":"16","author":"X Han","year":"2025","unstructured":"Han X, Zheng R, Zhang J, Liu Y, Li Z, Liu G, et al. Cardiomyocyte OTUD1 drives diabetic cardiomyopathy via directly deubiquitinating AMPK\u03b12 and inducing mitochondrial dysfunction. Nat Commun. 2025;16:6668.","journal-title":"Nat Commun"},{"key":"1891_CR6","doi-asserted-by":"publisher","first-page":"8624","DOI":"10.7150\/thno.48561","volume":"11","author":"M Zhang","year":"2021","unstructured":"Zhang M, Sui W, Xing Y, Cheng J, Cheng C, Xue F, et al. Angiotensin IV attenuates diabetic cardiomyopathy via suppressing FoxO1-induced excessive autophagy, apoptosis and fibrosis. Theranostics. 2021;11:8624\u201339.","journal-title":"Theranostics"},{"key":"1891_CR7","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1093\/cvr\/cvz014","volume":"115","author":"H Zhang","year":"2019","unstructured":"Zhang H, Ge S, He K, Zhao X, Wu Y, Shao Y, et al. FoxO1 inhibits autophagosome-lysosome fusion leading to endothelial autophagic-apoptosis in diabetes. Cardiovasc Res. 2019;115:2008\u201320.","journal-title":"Cardiovasc Res"},{"key":"1891_CR8","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1161\/01.RES.0000043825.01705.1B","volume":"91","author":"DL Mann","year":"2002","unstructured":"Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res. 2002;91:988\u201398.","journal-title":"Circ Res"},{"key":"1891_CR9","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41577-018-0065-8","volume":"18","author":"FK Swirski","year":"2018","unstructured":"Swirski FK, Nahrendorf M. Cardioimmunology: the immune system in cardiac homeostasis and disease. Nat Rev Immunol. 2018;18:733\u201344.","journal-title":"Nat Rev Immunol"},{"key":"1891_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110984","volume":"124","author":"X Han","year":"2023","unstructured":"Han X, Zhou W, Zhang J, Tu Y, Wei J, Zheng R, et al. Linderalactone mitigates diabetic cardiomyopathy in mice via suppressing the MAPK\/ATF6 pathway. Int Immunopharmacol. 2023;124:110984.","journal-title":"Int Immunopharmacol"},{"key":"1891_CR11","doi-asserted-by":"publisher","first-page":"H877","DOI":"10.1152\/ajpheart.00223.2019","volume":"317","author":"T Suetomi","year":"2019","unstructured":"Suetomi T, Miyamoto S, Brown JH. Inflammation in nonischemic heart disease: initiation by cardiomyocyte CaMKII and NLRP3 inflammasome signaling. Am J Physiol Heart Circ Physiol. 2019;317:H877\u201390.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1891_CR12","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1016\/j.molcel.2023.09.009","volume":"83","author":"M Ma","year":"2023","unstructured":"Ma M, Dang Y, Chang B, Wang F, Xu J, Chen L, et al. TAK1 is an essential kinase for STING trafficking. Mol Cell. 2023;83:3885\u2013903.e5.","journal-title":"Mol Cell"},{"key":"1891_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110280","volume":"120","author":"B Jin","year":"2023","unstructured":"Jin B, Wang J, Chen Y, Zuo W, Hong B, Li J, et al. Focal adhesion kinase induces cardiac remodeling through NF-\u03baB-mediated inflammatory responses in diabetic cardiomyopathy. Int Immunopharmacol. 2023;120:110280.","journal-title":"Int Immunopharmacol"},{"key":"1891_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1348043","volume":"15","author":"A Banerjee","year":"2024","unstructured":"Banerjee A, Singla DK. MSC exosomes attenuate sterile inflammation and necroptosis associated with TAK1-pJNK-NFKB mediated cardiomyopathy in diabetic ApoE KO mice. Front Immunol. 2024;15:1348043.","journal-title":"Front Immunol"},{"key":"1891_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49854-1","volume":"15","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Fan S, Zhu H, Zhao Q, Fang Z, Xu D, et al. Podocyte OTUD5 alleviates diabetic kidney disease through deubiquitinating TAK1 and reducing podocyte inflammation and injury. Nat Commun. 2024;15:5441.","journal-title":"Nat Commun"},{"key":"1891_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01262-x","volume":"19","author":"T Sun","year":"2020","unstructured":"Sun T, Liu Z, Yang Q. The role of ubiquitination and deubiquitination in cancer metabolism. Mol Cancer. 2020;19:146.","journal-title":"Mol Cancer"},{"key":"1891_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38605-3","volume":"14","author":"X Xiao","year":"2023","unstructured":"Xiao X, Shi J, He C, Bu X, Sun Y, Gao M, et al. ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy. Nat Commun. 2023;14:2859.","journal-title":"Nat Commun"},{"key":"1891_CR18","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature11831","volume":"494","author":"H Hu","year":"2013","unstructured":"Hu H, Brittain GC, Chang JH, Puebla-Osorio N, Jin J, Zal A, et al. OTUD7B controls non-canonical NF-\u03baB activation through deubiquitination of TRAF3. Nature. 2013;494:371\u20134.","journal-title":"Nature"},{"key":"1891_CR19","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.7150\/thno.103012","volume":"15","author":"C Ding","year":"2025","unstructured":"Ding C, Cao L, Wang R, Wu Q, Li M, Zhang J, et al. OTUD7B is a new deubiquitinase targeting p53. Theranostics. 2025;15:2121\u201338.","journal-title":"Theranostics"},{"key":"1891_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nature22344","volume":"545","author":"B Wang","year":"2017","unstructured":"Wang B, Jie Z, Joo D, Ordureau A, Liu P, Gan W, et al. TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling. Nature. 2017;545:365\u20139.","journal-title":"Nature"},{"key":"1891_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s13046-020-01751-3","volume":"39","author":"B Zhang","year":"2020","unstructured":"Zhang B, Yang C, Wang R, Wu J, Zhang Y, Liu D, et al. OTUD7B suppresses Smac mimetic-induced lung cancer cell invasion and migration via deubiquitinating TRAF3. J Exp Clin Cancer Res. 2020;39:244.","journal-title":"J Exp Clin Cancer Res"},{"key":"1891_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-65093-4","volume":"16","author":"K Harit","year":"2025","unstructured":"Harit K, Yi W, Jeron A, Schmidt J, Beckervordersandforth R, Wyler E, et al. Astrocytic-OTUD7B ameliorates murine experimental autoimmune encephalomyelitis by stabilizing glial fibrillary acidic protein and preventing inflammation. Nat Commun. 2025;16:9279.","journal-title":"Nat Commun"},{"key":"1891_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00766-2","volume":"13","author":"R Zheng","year":"2025","unstructured":"Zheng R, Song W, Wang C, Du X, Liu C, Sun X, et al. Deubiquitinase OTUD7B stabilizes HNF4\u03b1 to alleviate pressure overload-induced cardiac hypertrophy by regulating fatty acid oxidation and inhibiting ferroptosis. Biomark Res. 2025;13:53.","journal-title":"Biomark Res"},{"key":"1891_CR24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.029745","volume":"12","author":"B-B Du","year":"2023","unstructured":"Du BB, Zhang JL, Kong LY, Shi HT, Zhang DH, Wang X, et al. Ovarian tumor domain-containing 7B attenuates pathological cardiac hypertrophy by inhibiting ubiquitination and degradation of kr\u00fcppel-like factor 4. J Am Heart Assoc. 2023;12:e029745.","journal-title":"J Am Heart Assoc"},{"key":"1891_CR25","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1161\/CIRCULATIONAHA.123.065603","volume":"149","author":"SY Xie","year":"2024","unstructured":"Xie SY, Liu SQ, Zhang T, Shi WK, Xing Y, Fang WX, et al. USP28 serves as a key suppressor of mitochondrial morphofunctional defects and cardiac dysfunction in the diabetic heart. Circulation. 2024;149:684\u2013706.","journal-title":"Circulation"},{"key":"1891_CR26","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3390\/genes14040947","volume":"14","author":"AB Arrigo","year":"2023","unstructured":"Arrigo AB, Zhu W, Williams KA, Guzman-Moreno C, Lo C, Lin JHI. Contribution of LRP1 in human congenital heart disease correlates with its roles in the outflow tract and atrioventricular cushion development. Genes. 2023;14:947.","journal-title":"Genes"},{"key":"1891_CR27","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/s41401-023-01057-y","volume":"44","author":"JJ Zeng","year":"2023","unstructured":"Zeng JJ, Shi HQ, Ren FF, Zhao XS, Chen QY, Wang DJ, et al. Notoginsenoside R1 protects against myocardial ischemia\/reperfusion injury in mice via suppressing TAK1-JNK\/p38 signaling. Acta Pharm Sin. 2023;44:1366\u201379.","journal-title":"Acta Pharm Sin"},{"key":"1891_CR28","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1101\/gad.332395.119","volume":"33","author":"X Wu","year":"2019","unstructured":"Wu X, Liu S, Sagum C, Chen J, Singh R, Chaturvedi A, et al. Crosstalk between Lys63- and Lys11-polyubiquitin signaling at DNA damage sites is driven by Cezanne. Genes Dev. 2019;33:1702\u201317.","journal-title":"Genes Dev"},{"key":"1891_CR29","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.cellsig.2012.02.017","volume":"24","author":"Y Fan","year":"2012","unstructured":"Fan Y, Shi Y, Liu S, Mao R, An L, Zhao Y, et al. Lys48-linked TAK1 polyubiquitination at lysine-72 downregulates TNF\u03b1-induced NF-\u03baB activation via mediating TAK1 degradation. Cell Signal. 2012;24:1381\u20139.","journal-title":"Cell Signal"},{"key":"1891_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cellsig.2012.09.003","volume":"25","author":"L Liang","year":"2013","unstructured":"Liang L, Fan Y, Cheng J, Cheng D, Zhao Y, Cao B, et al. TAK1 ubiquitination regulates doxorubicin-induced NF-\u03baB activation. Cell Signal. 2013;25:247\u201354.","journal-title":"Cell Signal"},{"key":"1891_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110744","volume":"109","author":"H Qian","year":"2023","unstructured":"Qian H, Lu Z, Hao C, Zhao Y, Bo X, Hu Y, et al. TRIM44 aggravates cardiac fibrosis after myocardial infarction via TAK1 stabilization. Cell Signal. 2023;109:110744.","journal-title":"Cell Signal"},{"key":"1891_CR32","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.cmet.2021.05.019","volume":"33","author":"L Wang","year":"2021","unstructured":"Wang L, Zhang X, Lin ZB, Yang PJ, Xu H, Duan JL, et al. Tripartite motif 16 ameliorates nonalcoholic steatohepatitis by promoting the degradation of phospho-TAK1. Cell Metab. 2021;33:1372\u201388.e7.","journal-title":"Cell Metab"},{"key":"1891_CR33","doi-asserted-by":"publisher","first-page":"jem.20191644","DOI":"10.1084\/jem.20191644","volume":"217","author":"RKS Malireddi","year":"2020","unstructured":"Malireddi RKS, Gurung P, Kesavardhana S, Samir P, Burton A, Mummareddy H, et al. Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity-independent pyroptosis, apoptosis, necroptosis, and inflammatory disease. J Exp Med. 2020;217:jem.20191644.","journal-title":"J Exp Med"},{"key":"1891_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48708-0","volume":"15","author":"D Wang","year":"2024","unstructured":"Wang D, Li Y, Yang H, Shen X, Shi X, Li C, et al. Disruption of TIGAR-TAK1 alleviates immunopathology in a murine model of sepsis. Nat Commun. 2024;15:4340.","journal-title":"Nat Commun"},{"key":"1891_CR35","doi-asserted-by":"crossref","unstructured":"Xu D, Han J, Ye B, Lin L, Chen J, Jin Y, et al. USP13 ameliorates diabetic cardiomyopathy via deubiquitinating NLRP3 and inhibiting pyroptosis in cardiomyocytes. Cell Death Differ. 2025; 3:914\u201329.","DOI":"10.1038\/s41418-025-01612-6"},{"key":"1891_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167555","volume":"1871","author":"J Sun","year":"2025","unstructured":"Sun J, Jin X, Li Y. OTUD7B inhibited hepatic injury from NAFLD by inhibiting K48-linked ubiquitination and degradation of \u03b2-catenin. Biochim Biophys Acta Mol Basis Dis. 2025;1871:167555.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1891_CR37","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1080\/15548627.2022.2026098","volume":"18","author":"W Xie","year":"2022","unstructured":"Xie W, Tian S, Yang J, Cai S, Jin S, Zhou T, et al. OTUD7B deubiquitinates SQSTM1\/p62 and promotes IRF3 degradation to regulate antiviral immunity. Autophagy. 2022;18:2288\u2013302.","journal-title":"Autophagy"},{"key":"1891_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60123-7","volume":"16","author":"Z Kang","year":"2025","unstructured":"Kang Z, Yang M, Liu Y, Gui Y, Dong Y, Zhou H, et al. Myocardial mitochondrial antiviral signaling protein promotes heart Ischemia-reperfusion injury via RIG-I signaling in mice. Nat Commun. 2025;16:5101.","journal-title":"Nat Commun"},{"key":"1891_CR39","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3389\/fcimb.2019.00406","volume":"9","author":"RKS Malireddi","year":"2019","unstructured":"Malireddi RKS, Kesavardhana S, Kanneganti TD. ZBP1 and TAK1: master regulators of NLRP3 inflammasome\/pyroptosis, apoptosis, and necroptosis (PAN-optosis). Front Cell Infect Microbiol. 2019;9:406.","journal-title":"Front Cell Infect Microbiol"},{"key":"1891_CR40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3390\/ijms18010205","volume":"18","author":"Y Hirata","year":"2017","unstructured":"Hirata Y, Takahashi M, Morishita T, Noguchi T, Matsuzawa A. Post-translational modifications of the TAK1-TAB complex. Int J Mol Sci. 2017;18:205.","journal-title":"Int J Mol Sci"},{"key":"1891_CR41","doi-asserted-by":"publisher","first-page":"12710","DOI":"10.1073\/pnas.1008203109","volume":"109","author":"N Paquette","year":"2012","unstructured":"Paquette N, Conlon J, Sweet C, Rus F, Wilson L, Pereira A, et al. Serine\/threonine acetylation of TGF\u03b2-activated kinase (TAK1) by Yersinia pestis YopJ inhibits innate immune signaling. Proc Natl Acad Sci USA. 2012;109:12710\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1891_CR42","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nature10690","volume":"481","author":"L Zhang","year":"2011","unstructured":"Zhang L, Ding X, Cui J, Xu H, Chen J, Gong YN, et al. Cysteine methylation disrupts ubiquitin-chain sensing in NF-\u03baB activation. Nature. 2011;481:204\u20138.","journal-title":"Nature"},{"key":"1891_CR43","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.cellsig.2010.11.017","volume":"23","author":"Y Fan","year":"2011","unstructured":"Fan Y, Yu Y, Mao R, Zhang H, Yang J. TAK1 Lys-158 but not Lys-209 is required for IL-1\u03b2-induced Lys63-linked TAK1 polyubiquitination and IKK\/NF-\u03baB activation. Cell Signal. 2011;23:660\u20135.","journal-title":"Cell Signal"},{"key":"1891_CR44","doi-asserted-by":"publisher","first-page":"19341","DOI":"10.1073\/pnas.1110946108","volume":"108","author":"Q Li","year":"2011","unstructured":"Li Q, Yan J, Mao AP, Li C, Ran Y, Shu HB, et al. Tripartite motif 8 (TRIM8) modulates TNF\u03b1- and IL-1\u03b2-triggered NF-\u03baB activation by targeting TAK1 for K63-linked polyubiquitination. Proc Natl Acad Sci USA. 2011;108:19341\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1891_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/srep12300","volume":"5","author":"IT Chen","year":"2015","unstructured":"Chen IT, Hsu PH, Hsu WC, Chen NJ, Tseng PH. Polyubiquitination of transforming growth factor \u03b2-activated kinase 1 (TAK1) at lysine 562 residue regulates TLR4-mediated JNK and p38 MAPK activation. Sci Rep. 2015;5:12300.","journal-title":"Sci Rep"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01891-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01891-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01891-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:02:54Z","timestamp":1785783774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01891-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":45,"alternative-id":["1891"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01891-w","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}